Status:
COMPLETED
ACCESS A Master Digital Surveillance Protocol for COVID-19
Lead Sponsor:
Medable Inc.
Collaborating Sponsors:
Datavant
American Heart Association
Conditions:
Coronavirus
COVID
Eligibility:
All Genders
18+ years
Brief Summary
ACCESS enables individuals to contribute to critical research, via an iOS and Android smartphone mobile application. ACCESS combines patient reported outcomes, data from wearable devices and real-worl...
Detailed Description
In the urgency of the COVID-19 outbreak, Medable will enable an observational study protocol under which clinical trials can rapidly be conducted. The observational study protocol will include the con...
Eligibility Criteria
Inclusion
- Aged 18 years or older
- Able to provide electronic informed consent
- US Resident
- Read and comprehend English
Exclusion
- 1\. Do not have a personal smartphone
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT04363268
Start Date
April 20 2020
End Date
December 31 2022
Last Update
May 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medable Inc.
Palo Alto, California, United States, 94301